ATE309806T1 - Selenium enthaltende zusammensetzung zur behandlung von systemischen entzündungssyndromen - Google Patents

Selenium enthaltende zusammensetzung zur behandlung von systemischen entzündungssyndromen

Info

Publication number
ATE309806T1
ATE309806T1 AT99940254T AT99940254T ATE309806T1 AT E309806 T1 ATE309806 T1 AT E309806T1 AT 99940254 T AT99940254 T AT 99940254T AT 99940254 T AT99940254 T AT 99940254T AT E309806 T1 ATE309806 T1 AT E309806T1
Authority
AT
Austria
Prior art keywords
vitamin
systemic inflammatory
containing selenium
treatment
copper
Prior art date
Application number
AT99940254T
Other languages
English (en)
Inventor
Xavier Forceville
Dominique Vitoux
Original Assignee
Xavier Forceville
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xavier Forceville filed Critical Xavier Forceville
Application granted granted Critical
Publication of ATE309806T1 publication Critical patent/ATE309806T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/06—Chelate

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99940254T 1998-08-31 1999-08-30 Selenium enthaltende zusammensetzung zur behandlung von systemischen entzündungssyndromen ATE309806T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9810889A FR2782642B1 (fr) 1998-08-31 1998-08-31 Utilisation du selenium pour le traitement de patients atteints d'un syndrome de reponse inflammatoire systemique (sirs), et composition pour la mise en oeuvre du traitement
PCT/FR1999/002066 WO2000012101A2 (fr) 1998-08-31 1999-08-30 Composition contenant du selenium pour le traitement de patients atteints d'un syndrome de reponse inflammatoire systemique (sirs)

Publications (1)

Publication Number Publication Date
ATE309806T1 true ATE309806T1 (de) 2005-12-15

Family

ID=9530002

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99940254T ATE309806T1 (de) 1998-08-31 1999-08-30 Selenium enthaltende zusammensetzung zur behandlung von systemischen entzündungssyndromen

Country Status (12)

Country Link
US (2) US6844012B1 (de)
EP (1) EP1107767B1 (de)
JP (1) JP4955147B2 (de)
AT (1) ATE309806T1 (de)
AU (1) AU760534B2 (de)
BR (1) BR9913339A (de)
CA (1) CA2341601C (de)
DE (1) DE69928410T2 (de)
DK (1) DK1107767T3 (de)
ES (1) ES2252963T3 (de)
FR (1) FR2782642B1 (de)
WO (1) WO2000012101A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2409688A1 (en) * 2000-05-25 2001-11-29 Pharmaton S.A. Method for improving the cell protection
EP1205471A1 (de) * 2000-10-02 2002-05-15 PharmaSe, Incorporated Verfahren zur Anwendung von synthetischem L-Se-Methylselenocystein als Nahrungs- und Heilmittel und Verfahren zu seiner Herstellung
ES2329984T3 (es) * 2001-05-16 2009-12-03 Serenite - Forceville Procedimiento para el diagnostico in vitro o para la monitorizacion de una enfermedad que implica una reaccion inflamatoria.
US7449451B2 (en) * 2001-08-29 2008-11-11 Premier Micronutrient Corporation Use of multiple antioxidant micronutrients as systemic biological radioprotective agents against potential ionizing radiation risks
US6849613B2 (en) 2001-08-29 2005-02-01 Kedar N. Prasad Multiple antioxidant micronutrients
US20040110691A1 (en) * 2001-11-13 2004-06-10 Stamler Jonathan S. Thiol reactive agents as a therapeutic modality
AT412703B (de) 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
EP1374892A1 (de) * 2002-06-28 2004-01-02 Braun, Jan Matthias, Dr. Arzneimittel zur Behandlung von infektiösen Krankheiten infolge Neisseria Meningitidis
DE10321029A1 (de) * 2003-05-10 2004-12-02 Sigrid Heide Arzneimittel mit Selenit
DE10349115A1 (de) * 2003-10-22 2005-06-16 Biosyn Arzneimittel Gmbh Kombinationspräparat zur Behandlung der Sepsis
FR2873376B1 (fr) * 2004-07-23 2006-11-24 Tetrahedron Sas Nouveaux seleno-hydroxyacides et leurs derives, applications en nutrition, cosmetique et pharmacie
FR2883884B1 (fr) * 2005-03-30 2012-11-09 Lallemand Sas Preparation de levures a proprietes anti-oxydantes ameliorees et leurs applications
US7901710B2 (en) * 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US7998500B2 (en) * 2005-08-04 2011-08-16 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US8263137B2 (en) * 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US8202546B2 (en) * 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US20070082064A1 (en) * 2005-10-12 2007-04-12 Krawitz Paul L Nutritional or dietary supplement for the treatment of macular degeneration
US7897800B2 (en) * 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) * 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
AU2006337161B2 (en) 2006-02-03 2012-06-07 Obagi Cosmeceuticals Llc Anti-aging treatment using copper and zinc compositions
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US20100129413A1 (en) * 2006-12-28 2010-05-27 Nutrition 21, Inc. Method of treating and preventing viral infections
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
US20090208543A1 (en) * 2008-01-22 2009-08-20 Oral Health Clinical Services Method and apparatus for applying a protective oral care composition
JP2011521908A (ja) * 2008-05-09 2011-07-28 デューク ユニバーシティ チオレドキシンが細胞における一酸化窒素放出を調節するという知見に基づく疾患の治療法
WO2010085753A1 (en) 2009-01-23 2010-07-29 Jr Chem, Llc Rosacea treatments and kits for performing them
US20110008271A1 (en) * 2009-07-13 2011-01-13 Jr Chem, Llc Rosacea treatments using polymetal complexes
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
AT511159A1 (de) 2011-02-16 2012-09-15 Selo Medical Gmbh Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen
US10499682B2 (en) 2014-08-25 2019-12-10 New Age Beverage Corporation Micronutrient formulation in electronic cigarettes
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
FR3037798A1 (fr) 2015-06-25 2016-12-30 Serenite-Forceville Composition comprenant au moins un compose selenie pour le traitement du sepsis et/ou de toute hyper-inflammation generalisee (sirs) ou cellulaire dommageable
EP3675846A4 (de) * 2017-08-29 2021-05-19 National Jewish Health Verfahren und zusammensetzungen zur behandlung von infektionen und entzündungen mit selenocyanat
US12110564B2 (en) 2018-05-07 2024-10-08 Yale University Test to distinguish viral-only from bacterial infection or viral/bacterial coinfection using a respiratory swab
CN111568921A (zh) * 2020-04-20 2020-08-25 奥格生物技术（六安）有限公司 一种促进冠状病毒患者康复的新型硒制剂配方及其制备方法
KR20230058047A (ko) 2020-07-02 2023-05-02 아메리칸 리전트, 인크. 미량 원소 조성물, 그 제조 및 사용 방법
CN111748533B (zh) * 2020-07-03 2021-04-02 华中农业大学 白蚁SelT基因及其dsRNA结合金龟子绿僵菌在白蚁防治中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5929063A (en) * 1995-03-24 1999-07-27 Children's Hospital Medical Center Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
IT1290907B1 (it) * 1997-01-31 1998-12-14 Idi Farmaceutici Spa Composizione per prodotto dietetico efficace nel combattere lo stress ossidativo e il decadimento cellulare.
GB9722361D0 (en) * 1997-10-24 1997-12-17 Pharma Nord Uk Ltd Pharmaceutical formulation for treating liver disorders

Also Published As

Publication number Publication date
JP4955147B2 (ja) 2012-06-20
EP1107767B1 (de) 2005-11-16
DE69928410D1 (de) 2005-12-22
BR9913339A (pt) 2001-05-15
WO2000012101A3 (fr) 2000-06-15
JP2002523463A (ja) 2002-07-30
AU760534B2 (en) 2003-05-15
WO2000012101A2 (fr) 2000-03-09
AU5427099A (en) 2000-03-21
ES2252963T3 (es) 2006-05-16
FR2782642A1 (fr) 2000-03-03
US20050163862A1 (en) 2005-07-28
CA2341601C (fr) 2011-10-25
DK1107767T3 (da) 2006-04-03
US7635491B2 (en) 2009-12-22
FR2782642B1 (fr) 2001-12-07
DE69928410T2 (de) 2006-08-03
CA2341601A1 (fr) 2000-03-09
US6844012B1 (en) 2005-01-18
EP1107767A2 (de) 2001-06-20

Similar Documents

Publication Publication Date Title
ATE309806T1 (de) Selenium enthaltende zusammensetzung zur behandlung von systemischen entzündungssyndromen
MXPA02002681A (es) Uso de metabolitos de acido alfa-linolenico para el tratamiento o prevencion del cancer.
TR200001203T2 (tr) Yeni birleşik maddeler
DE69905368D1 (en) Oxydiertes thymosin beta 4
ATE236870T1 (de) Substituierte 2-phenyl-1-(3,4-dihydroxy-5- nitrophenyl)-1-ethanone, deren verwendung zur behandlung von erkrankungen des zentralen und periphären nervensystems und diese enthaltende pharmazeutische zusammensetzungen
DE69835824D1 (de) Antitumorkombination aus 3-amino-1,2,4-benzotriazine 1,4-dioxid/paclitaxel/platin
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
DE60031016D1 (de) Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen
DE60320034D1 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
AU1556800A (en) Hyperforin as cytostatic agent and hyperforin ointment or cream as application form
ATE500269T1 (de) Verbindungen mit wachstumshormon-freisetzenden eigenschaften
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
DE60108402D1 (de) Verwendung einer pollenextrakt-haltigen verbindung zur behandlung erkrankungsbedingter gewichtszunahme
TR200200987T2 (tr) Kanser tedavisine yönelik,ornatılmış pirroller
ATE224195T1 (de) Glucocorticoide zur behandlung von glomerulonephitis
ATE232541T1 (de) Gallensauersälze mit physiologisch aktiven metalle und ihre verwendung zur therapeutischen behandlung
MD980129A (en) Antiherpetic remedy
NO20012169L (no) Forbindelser med veksthormonfrigjörende egenskaper
ES2160093A1 (es) Derivados del acido p-hidroxifenil propionico como agentes antiproliferativos.
DE69428276D1 (de) Insulinähnlicher wachstumfaktor ii als antitumormittel
Han Changes in the Nursing Related Regulations-in Medical Law
NZ501687A (en) A medical composition comprising a combination of one or more honeys with one or more gelling agents to form a pliable solid
UA36030A (uk) Препарат для лікування і профілактики респіраторних хвороб коней " сегп "

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1107767

Country of ref document: EP